Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
29.80
-1.27 (-4.09%)
At close: Feb 11, 2026, 4:00 PM EST
29.78
-0.02 (-0.07%)
After-hours: Feb 11, 2026, 4:32 PM EST
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $2.36 billion as of February 11, 2026. Its market cap has increased by 373.87% in one year.
Market Cap
2.36B
Enterprise Value
1.71B
1-Year Change
373.87%
Ranking
Category
Stock Price
$29.80
Market Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $2.36B, an increase of 277.40%. That is a compound annual growth rate of 55.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 2.46B | -14.38% |
| Dec 31, 2025 | 2.87B | 368.78% |
| Dec 31, 2024 | 612.65M | 73.31% |
| Dec 29, 2023 | 353.50M | -43.43% |
| Feb 10, 2023 | 624.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunome | 2.70B |
| Beam Therapeutics | 2.69B |
| Travere Therapeutics | 2.69B |
| Spyre Therapeutics | 2.64B |
| Arcus Biosciences | 2.61B |
| Wave Life Sciences | 2.50B |
| Adaptive Biotechnologies | 2.44B |
| Telix Pharmaceuticals | 2.42B |